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To investigate the receptor-like molecule(s) for plasminogen (PGn) on the neuronal surface, the properties of binding of PGn to the plasma 
membrane of cultured embryonic rat neocortical neurons were investigated. [‘*‘I]PGn was found to specifically bind to the plasma membrane 
depending on the incubation temperature and time. The binding was also affected strongly by ionic strength and slightly by Ca’+. Furthermore, 
ligand blotting analysis revealed that [‘251]PGn binds to a major protein with an apparent molecular weight of 45 kDa among plasma membrane 
proteins. These results suggest hat the 45kDa protein is a PGn receptor-like molecule on the neuronal surface. 
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1. INTRODUCTION 
Plasminogen (PGn) is an inactive zymogen, which is 
converted to an active protease, plasmin, by plasmino- 
gen activators, and was originally accepted to serve as 
fibrinolysin [l]. Until recent years, the zymogen was 
believed to be produced in the liver [2,3]. However, we 
recently found that PGn is produced in cultured rat 
microglia [4,5], a type of glial cell in the central nervous 
system, and secreted extracellularly. Furthermore, we 
showed that zymogen had potent activity as a neurotro- 
phic factor in vitro [6,7]. PGn promotes neurite out- 
growth in neocortical explants [6] and enhances the sur- 
vival and/or maturation of dopaminergic neurons in 
mesen~phalic neurons [7]. These effects of PGn allow 
us to speculate that PGn binds to specific receptor-like 
molecule(s) on the plasma membrane of the neurons 
and exerts neurotrophic activity. This idea was sup- 
ported by our previous finding that PGn specifically 
binds to cultured neurons [6]. 
In the present studies we have further studied the 
binding of PGn on the neuronal plasma membrane. The 
data provide evidence that PGn specifically binds to the 
neuronal plasma membrane, and that a protein with a 
molecular mass of 45 kDa, which is associated with the 
neuronal plasma membrane, is the receptor for binding 
of PGn. 
*Corresponding author. Fax: (81) (423) 46 175 1. 
As a mitochondrial marker enzyme, cytochrome c oxidase (EC 
1.9.3.1) activity was measured according to the method of Hodges et 
al. [13]. The reaction at 25’C was monitored by recording the decrease 
of absorbance at 550 nm. The enzyme unit was calculated by using 
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2. MATERIALS AND METHODS 
2.1. Materials 
Cytochrome c (from horse heart), P-nitrophenyl phosphate and 
S-adenosine mono phosphate (5’-AMP) were purchased from Wako 
Pure Chemical Industries; 6-amino caproic acid, benzamidine and 
cytochrome c oxidase (bovine heart) from Sigma Chemical Co., lysine 
from Kyowa Hakko Kogyo; ~uco~6-phosphate from Nacalai 
TESQUE; human pro~rombin (22.2 U/mg) from Enzyme Research 
Laboratories; human urokinase (140,000 IU/mg protein) from 
Mochida Pharmaceutical Co.; Sephadex G-150, Percoll and protein 
molecular weight markers from Pharmacia LKB; ‘25I (3.7 GBq/ml) 
from Amersham Corp. and poly~~l~de gel (l&20% gradient gel) 
from Daiichi Pure Chemical Co.; X-ray fibn (XARS) was supplied by 
Eastman Kodak Co. Materials and chemicals for neuronal culture 
were described elsewhere [8,9]. All other reagents were of analytical 
grade. 
2.2. Neuronal culture 
Neocortical neurons were prepared from 16-day embryonic rat 
brain as described previously [lo]. In brief, the dissociated neurons 
were cultured in poly-L-iysin~oat~ plastic culture dishes at a density 
of 1.5-2.0 x lo’/75 cm2 for 3 days. The cell purity was over 97%, 
judged by immunocytochemical study with neurofilament antibody 
[lOI. 
2.3. Determ~nutjon of marker enzyme activity 
The activity of 5’nucleotidase (EC 3.1.3.5) as a marker for the 
plasma membrane was determined essentially by the method of Cam- 
mer [1 11. A reaction mixture containing 100 mM Tris-HCl (pH 7.5), 
10 mM MgSO,, 10 mM AMP and a sample (- 20~1) solution in a total 
volume of 100 ~1 was incubated for 15 min at 37*C. The reaction was 
stopped by the addition of 100 ~1 of 20% trichloro acetic acid (TCA), 
and the unhydrolyzed AMP was precipitated by centrifugation. The 
amount of phosphate in the supematant was determined by the 
method of Chen et al. [12]. 
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cytochrome c oxidase (100 U/7.7 mg of solid) from Sigma, in which 
one unit was defined as 1 pmol of substrate catalyzed in one minute. 
Acid phosphatase (EC 3.1.3.2) activity as a lysosomal marker en- 
zyme was determined by measuring at 405 nm the amount of P- 
nitrophenol released from P-nitrophenyl phosphate as substrate [14]. 
As an endoplasmic reticulum marker enzyme, glucose-(i-phosphat- 
ase (EC 3.1.3.9) activity was determined according to the method of 
Heymann et al. [15]. The reaction was stopped by the addition of 0.1 
ml of 50% TCA. The liberated phosphate was determined by the 
method of Chen et al. [12]. 
The amounts of protein were measured by the method of Lowry et 
al. [16] by using bovine serum albumin as a standard protein. 
2.4. lodination of rat PGn 
Rat PGn was isolated from adult rat plasma as described previously 
[4,5]. The purified rat PGn was iodinated by a slight modification of 
the chloramine T method (6,171. The iodinated plasminogen was sep- 
arated from free “‘1 by Sephadex G-150 gel filtration with 20 mM 
Tris-HCl (pH 7.5) buffer containing 100 mM NaCl. The specific activ- 
ity was 6.7 x lo5 dpm@g of plasminogen. The [“‘I]PGn showed a 
single peak at around 90-100 kDa in glycerol gradient centrifugation 
(210% glycerol, 257,600 g,,, 6 h, Hitachi PRS 65T) (Fig. lA), and 
could be activated by urokinase as shown by casein-uro~nase-zy- 
mography [4] (Fig. IB), indicating that [‘251]PGn retains the native 
properties as a zymogen without aggregation or degradation. 
2.5. Cell fractionation 
Three day-cultured neurons were harvested by scraping with a rub- 
ber policeman and precipitated by low-speed centrifugation. The col- 
lected neurons were homogenized in HO buffer [20 mM Tris-HCl (pH 
7.5), 0.2 M KCI, 5 mM EDTA, 0.32 M sucrose] by using a Teflon 
homogen~er (clearance - 0.2 mm) with 10 up-and-down strokes by 
hand. The homogenate was centrifuged for 10 min at 1000 x g, and 
the supernatant (S,) was then centrifuged for 30 min at 35,000 x g. The 
supematant (S,) was removed and the resulting pellet was suspended 
with the HO buffer and used as the crude plasma membrane fraction 
(PZ). Plasma membrane and mitochondria in the crude plasma mem- 
brane fraction were separated by Percoll gradient centrifugation ac- 
cording to the method of Belsham [18]. The P, fraction (about 2 mg 
of protein!200 ~1) was layered over 3 ml of a 20% Percoll solution 
containing 20 mM Tris-HCI (pH 7.5), 0.2 M KCI, and 5 mM EDTA, 
A 
and centrifuged at 30,000 x g, for 17 min with slow-accele starting 
(Beckman TLlOO, TLA 3 rotor). The resultant Percoll gradient was 
divided into 17 fractions by aspirating the solution from the bottom 
of the tube, and assayed for enzyme activity. For further experiments, 
resultant layers (plasma membrane in the upper position and mito- 
chondria in the lower position) were collected with a Pasteur pipette, 
and precipitated by centrifugation of 250,000 x g for 60 min. The 
precipitates of plasma membrane and mitochondria were resuspended 
with HO buffer, and washed once with the same buffer. The plasma 
membrane preparation was stored at -80°C until used. 
2.6. PGn binding assay by centrijiigation method 
The standard reaction mixture, containing 20 mM Tris-HCl (pH 
7.5), 100 mM NaCl, 200 nM [“‘I]PGn and 10 pig of protein of the 
plasma membrane in a total volume of 50 ~1, was incubated at 22°C 
for _ 24 h with or without an excess of unlabeled rat PGn (40 PM), 
and then centrifuged for 5 min at 18,500 x g. The resulting pellet was 
resuspended in 50 ~1 of the washing solution (20 mM Tris-HCl @H 
7.5), 100 mM NaCI) with a vortex mixer for 10 s, and immediately 
centrifuged as above. After removal of the supematant, he radioactiv- 
ity in the pellet was measured in a gamma counter (Packard cobra II). 
Specific binding of PGn was calculated by subtracting non-specific 
binding measured in the presence of excess cold rat PGn (200 times 
the [“‘I]PGn) from the total binding. In some experiments, various 
buffers with different concentrations of NaCl (50-600 mM), CaCl, 
(04 mM) and MgC& (o-4 mM) were used for the reaction mixture 
and corres~nding washing solution. 
2.7. Ligand blotting for PGn 
The plasma membrane fraction was solubilized with an equal vol- 
ume of SDS sample buffer (125 mM Tris-HCl (pH 6.8), 4.6% SDS, 
20% glycerol). After being heated at 90°C for 3 min, samples were 
subjected to SDS-PAGE with l&20% gradient gels according to the 
method of Laemmli [19], and their proteins were transferred to Immo- 
bilon P with a semi-dry transblot apparatus in the presence of 0.01% 
SDS and 20% methanol. As a standard condition, the Immobilon 
membrane strips were blocked with 3% BSA in TNMC buffer (20 mM 
Tris-HCl (pH 7..5), 100 mM NaCl, 2 mM M&l,, 2 mM CaCl,) for 1 
h and incubated with 5 pg of [“‘I]PGn per 10 ml of TNMC buffer 
containing 3% BSA. After being washed with TNMC buffer for 2 h, 
the membrane was dried, and autoradio~aph~ with X-ray film. On 
B 
Fig. 1. Properties of [‘251]PGn. (A) Glycerol gradient centrifugation. [‘251]PGn (6 x lo6 cprr&O ~1) was overlayed on 5 ml of a glycerol gradient 
(2210%) containing 20 mM Tris-HCI (pH 7.5), 100 mM NaCl, and 1 mM MgCl,, and centrifuged at 240,~O x g,,, for 6 h. The gradient was 
fractionated by releasing 5 drops (about 130 ~1) from the bottom, and a sample was removed and counted. ALD, BSA and CYT are the positions 
where aldolase (MW 158 kDa), bovine serum albumin (MW 68 kDa) and cytochrome c (MW 12.5 kDa) were eluted, respectively. (B) Casein- 
zymography for PGn. [“‘I]PGn (l.Opg) was subjected to SDS-PAGE with three lanes. One was stained with Coomassie blue (1). The others were 
washed for 1 h with 50 mM Tris-HCI (pH 7.5), 2.5% Triton X-100, to eliminate SDS and subjected to casein-zymography in the presence (2) or 
absence (3) of urokinase as described previously [4]. 
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Fig. 2. Preparation of plasma membrane by Percoll gradient centrifu- 
gation. The crude plasma membrane fraction (P2) was subjected to 
Percoll gradient centrifugation as described in section 2. After centrif- 
ugation, the gradient was fractionated into 17 tubes and each fraction 
was assayed for S-nucleotidase (o-o) and cytochrome coxidase activ- 
ity (0-o). 
the other hand, for protein staining of the transblotted proteins, the 
membrane was soaked in 0.1% Coomassie brilliant blue R250 for 5 
min, and destained with an adequate con~ntration of methanol. 
3. RESULTS 
3.1. Piasma membrane from cultured neurons 
A neuronal plasma membrane was prepared by Per- 
co11 gradient ~nt~fugation as described in section 2. 
The isolation profiles are shown in Fig. 2. The plasma 
membrane fraction (numbers 10-12) showed hardly any 
contamination with cytochrome c oxidase, while the 
mitochondria fraction (numbers 4-6) were contained 
with a considerable amount of S-nucleotidase. 
The activities of marker enzymes in the recovered 
plasma membrane and other subcellular fractions are 
summarized in Table I. Hardly any cytochrome c oxi- 
dase activity was present in the membrane fraction, as 
is consistent with the results shown in Fig. 2. In addi- 
tion, relatively low glucose-6-phosphatase and acid 
phosphatase activity in the plasma membrane fraction 
showed that the fraction was not contaminated with 
microsomes or lysosomes. These results indicate that a 
highly enriched fraction of the neuronal plasma mem- 
brane can be obtained by Percoll gradient centrifuga- 
tion. From 0.6-0.7 g (wet weight) of cultured neurons, 
about l-2 mg of protein of the plasma membrane could 
be obtained. 
3.2. Characterization of speciJc binding of PGn to the 
plasma membrane 
To characterize the PGn binding on the neuronal 
plasma membrane in detail, a small-scale ~nt~fugation 
method was employed. As shown in Fig. 3, about 7 
pmol of [‘*‘I]PGn bound to the plasma membrane (10 
pg of protein). The binding of [‘251]PGn to the plasma 
membrane was inhibited in the presence of unlabeled rat 
PGn (IOO- to 200-fold), but was not affected by 
prothrombin or urokinase. Lysine and its analogue, 6- 
amino caproic acid, and benzamidine also inhibited 
PGn binding, suggesting that PGn specifically binds to 
the neuronal membrane through the lysine-binding do- 
main as found in the case of the binding to fibrin [20]. 
The specific binding of PGn to the plasma membrane 
was also examined at different temperatures (Fig. 4) and 
was found to be higher at 37°C. At 22’C, PGn binding 
was only about 50% of that observed at 37°C. However, 
the binding tended to decrease from 6 h to 12 h at 37°C. 
Fig. 5A shows the effect of ionic strength on the 
specific PGn binding to the plasma membrane. Changes 
in NaCl concentration caused marked alteration of PGn 
binding. The PGn binding was found to be higher at 
lower NaCl concentrations. Furthermore, to examine 
the requirement of divalent cations in the PGn binding, 
Ca*+ or MgZ’ was added to the reaction mixture (Fig. 
5B). The specific binding of PGn increased slightly de- 
pending on Ca*’ concentration up to 4 mM. Although 
not shown, no further increase was observed at over 5 
mM Ca2+. In addition, no significant stimulation was 
seen when Mg? was present. 
Table I 
Marker enzyme activities showing the purity of subcellular fractions 
Fraction 5’-Nucleotidase Cytochrome c oxidase Acid phosphatase Glucose-6phosphatase 
(nmol P/miu/mg protein) (Unitlmg protein) (nmol P/min/mg protein) (nmol P/min/mg/protein) 
Homogenate 6.5 zt 0.8 8.04It 1.46 57.6 ?I 3.6 3.87 f 0.43 
Sl 5.6 + 1.0 14.58 dI 0.00 45.0 & 2.9 n.d. 
PL! 13.9 + 1.0 37.92 f 2.92 91.2 + 3.2 3.62 f 0.18 
SZ 0.1 f 0.0 1.46+ 1.20 21.2 Z!I 3.1 n.d. 
Plasma membrane 12.3 Z!Z 0.9 4.38 f 2.62 39.7 jI 1.9 1.09 f 0.07 
Mitochondria 14.0 + 3.2 87.50 + 16.04 66.5 i: 1.7 7.61 k 0.24 
The marker enzyme activities in each fraction were determined as described in section 2. The values are expressed as the mean of three independent 
experiments. nd.: not determined. 
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Fig. 3. Specificity of PGn binding to the neuronal plasma membrane. 
The binding of [‘251]PGn to the plasma membrane was examined in 
the presence of the indicated concentration of rat PGn, prothrombin 
(pro Th), urokinase (UK), 6-amino caproic acid (6ACA), lysine (Lys) 
or benzamidine (Bz) under the standard reaction condition. The incu- 
bation was carried out at 22°C for 12 h. 
3.3. Ligand blotting analysis 
As PGn was suggested to specifically bind to the 
plasma membrane, the molecules for PGn binding were 
surveyed by ligand blotting under the standard condi- 
tion (20 mM Tris-HCl (pH 7.5) 100 mM NaCl, 2 mM 
MgCl,, 2 mM CaCl,) (Fig. 6). [‘251]PGn bound mainly 
to a protein with a molecular weight of about 45 kDa 
(lane 2). This binding was clearly inhibited when an 
excess amount of cold PGn or 6ACA was present in the 
reaction mixture (lanes 3 and 4), suggesting that PGn 
specifically binds to the 45kDa protein through the 
lysine-binding domain(s). 
4. DISCUSSION 
As previously reported, microglia-secretory plasmin- 
ogen has potential activity as a neurotrophic factor, 
such as stimulation of neurite outgrowth [6] and dopam- 
ine uptake [7], in cultured neurons. Together with these 
6 12 24 
-m(h) 
Fig. 4. Time and temperature dependency of the PGn binding. The 
specific binding of [‘*‘I]PGn to the plasma membrane was examined 
at 37°C (o-o), 22°C (O-O) and 4°C (A-A) under the standard reaction 
conditions. 
biological activities, PGn was found to specifically bind 
to cultured neurons. These findings have suggested that 
PGn, like established growth factors, binds to certain 
specific receptor protein(s) on the neuronal surface, 
through which PGn-specific signal transductions are in- 
duced in neurons. 
In the present study, we first characterized the specific 
binding of PGn to neuronal plasma membranes. High 
purity plasma membranes can be isolated by Percoll 
gradient centrifugation. The method is simple and re- 
producible, and has the advantage of eliminating mito- 
chondria from the crude plasma membrane fraction 
(PJ. Like other cultured cells [21], the plasma mem- 
brane has higher 5’-nucleotidase activity than the other 
fractions. Such plasma membranes would be suitable 
starting materials for purification of a PGn-binding 
protein. 
We investigated the characteristics of PGn binding to 
the neuronal membrane by using a simple centrifuga- 
tion binding assay. Specific binding of PGn to the 
plasma membrane was demonstrated to be dependent 
on incubation temperature and incubation time. Fur- 
thermore, the binding was highly affected by ionic 
strength and slightly affected by Ca*‘. In addition, al- 
though the data are not shown, we observed that the 
binding was also affected by the pH (6.5-8.5) of the 
reaction mixture. The amount of specific binding was 
higher in the acidic condition. It seems that PGn bind- 
ing is delicately modulated by a variety of inoic condi- 
tions including ionic strength and divalent cations, and 
these effecters in combination with pH may act as phys- 
iological modulators of PGn binding in the extracellular 
microenvironment. However, we think that the most 
Fig. 5. Effect of ionic strength and Ca”, Me on the specific binding 
of [‘*‘I]PGn. (A) Effect of ionic strength. The specific binding of 
[‘251]PGn to the plasma membrane was examined at the indicated 
NaCl concentrations in the standard reaction mixture. Buffer solution 
containing the same concentration of NaCl was also used for washing. 
(B) Effect of Ca*’ or Mg2+. The specific binding of PGn was examined 
in the presence of CaCl, (- 4 mM) or MgCl, (- 4 mM) in the standard 
reaction mixture. The same concentration of CaCI, or MgCI, was used 
for washing. 
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Fig. 6. Ligand blotting for PGn binding proteins. The plasma mem- 
brane (20 pug of protein/lane) was subjected to SDS-PAGE under the 
non-reduced condition, and the proteins were transferred to Immo- 
bilon. One strip was stained with Coomassie blue (lane 1). The others 
were incubated with [“‘I]PGn in the absence (lane 2) or presence of 
ZOO-fold amounts of PGn (lane 3) or 0.2 M 6ACA (lane 4) as described 
in section 2. 
significant and important binding condition is the phys- 
iological circumstance such as phosphate buffered sa- 
line (Dulbecco’s, Earl’s or Hanks’ solution). 
The presence of specific binding protein(s) for PGn 
in the neuronal plasma membrane was examined by 
ligand blotting, and mainly a 45-kDa protein was dem- 
onstrated to bind PGn in the physiolo~cal condition. 
Although a few minor proteins other than 45-kDa were 
detected in cell homogenates of neurons, these proteins 
were not associated with the plasma membrane. From 
these results, a 45-kDa protein is focused on as a pri- 
mary candidate for a PGn receptor-like molecule in the 
neuronal plasma membrane. The binding of [‘*‘I]PGn 
to a 45-kDa protein of the plasma membrane was 
strongly affected by ionic strength. The intensity of 12’1 
tended to be high at lower concentrations of NaCl (C 50 
mM), consistent with the result obtained in the centrifu- 
gation binding assay. In addition, the presence of Ca2’ 
or a change in pH also changed the degree of PGn- 
binding to the 45-kDa protein. Recently, it was shown 
that PGn binds to a variety of cells such as platelets [17], 
monocytes, granulocytes and l~phocytes [22], endo- 
thelial cells [23-251, hepatocytes [26], a tumor cell line 
[27], a fibroblast cell line, a monocytic cell line [28] and 
glioma cells [29]. Among these cells, endothelial cells 
[30,3 l] and U937 monocytoid [32] were reported to have 
45- to 46-kDa and 54-kDa proteins for interacting with 
PGn, respectively. Whether there is a correlation among 
those proteins and neuronal 45-kDa protein in the pres- 
ent study is interesting. 
The results involving the method of preparation of 
neuronal plasma membrane and binding characte~stics 
of PGn may be valuable for obtaining further informa- 
tion about the regulation of PGn binding to the neurons 
and for the purification of the PGn-binding protein. 
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